Diagnosis of EGFR exon21 L858R point mutation as lung cancer biomarker by electrochemical DNA biosensor based on reduced graphene oxide/functionalized ordered mesoporous carbon/Ni-oxytetracycline metallopolymer nanoparticles modified pencil graphite elect

Y. Shoja, A. Kermanpur, F. Karimzadeh; "Diagnosis of EGFR exon21 L858R point mutation as lung cancer biomarker by electrochemical DNA biosensor based on reduced graphene oxide/functionalized ordered mesoporous carbon/Ni-oxytetracycline metallopolymer nanoparticles modified pencil graphite electrode", Biosens. Bioelectron., 2018, 113, 108-115.

Link To Online Resource:

https://www.ncbi.nlm.nih.gov/pubmed/29753165